Humasis Co. Ltd. (KOSDAQ:205470)
South Korea · Delayed Price · Currency is KRW 1,325.00
-14.00 (-1.05%)
Aug 29, 2025, 12:39 PM KST
Humasis Market Cap
Humasis has a market cap or net worth of 151.51 billion as of August 28, 2025. Its market cap has decreased by -21.51% in one year.
Market Cap
151.51B
Enterprise Value
-7.18B
Revenue
29.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,325.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 151.51B, an increase of 1,307.69%. That is a compound annual growth rate of 39.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 151.51B | -18.20% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | 324.84B | 729.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.60T |
| Celltrion | 37.98T |
| ALTEOGEN | 22.61T |
| Yuhan | 8,694.51B |
| SK Biopharmaceuticals | 7,893.98B |
| Peptron | 7,396.91B |
| PharmaResearch | 7,314.31B |
| LigaChem Biosciences | 5,419.69B |